EGFR and lung adenocarcinoma: Only the ferroptosis suppressor gene CA9 was identified to be upregulated in gefitinib-resistant cells and predicted poor prognosis in 39 EGFR-mutant lung adenocarcinoma patients (the training set) from the TCGA database (Figure 1(e) and Supplementary Figure S1 (a, b)).